Skip to main content
PGProcter & Gamble Company (The)Hold5.7·$150.94-0.72%
PG · Why this verdict

Why Procter & Gamble Company (The) (PG) is rated HOLD

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictHOLD
Overall score5.7/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Procter & Gamble has beaten earnings estimates in all 4 recent quarters, generates a 31% ROE with a wide economic moat, and exhibits strong momentum with rising on-balance volume, but the stock is priced above analyst targets with -2.2% upside and carries significant geographic and supplier concentration risks.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Procter & Gamble generates a 31% return on equity with 19% operating margins and ranks in the top decile of consumer staple peers on both ROE and margin quality, demonstrating durable pricing power across its household brands.

Stable
Quality breakdown
Expectation
ROE remains above 28% and operating margins stay above 17% over the next 4 reported quarters.

CounterA 31% ROE is substantially driven by financial leverage; stripping out debt effects, the underlying return on assets is more modest, and margin pressure from commodity input costs could compress results faster than expected.

Procter & Gamble has beaten EPS estimates in all 4 most recent quarters with an average upside surprise of 3.1%, combined with a wide economic moat score of 7.6 and a Piotroski F-Score of 8/9, marking it as a high-quality compounder.

Stable
Catalyst breakdown
Expectation
EPS beats continue in all 4 of the next 4 quarters with average positive surprise above 2% and the moat score stays above 7.0.

CounterSmall but consistent earnings beats in large-cap consumer staples often reflect conservative guidance practices rather than genuine outperformance; the 3.1% average is modest and could be disrupted by a single quarter of volume weakness.

Procter & Gamble has high-priority concentration risks in non-US operations and single-source suppliers for key inputs, creating two structural vulnerabilities to geopolitical disruption and supply chain shocks.

Stable
Bear case
Expectation
Neither concentration risk results in material revenue or margin impact of more than 3% in any single reported quarter.

CounterPG's global footprint spanning 180+ countries is among the most diversified in consumer staples; geographic concentration is relative and the company has decades of experience managing FX and geopolitical risks.

The stock is priced above the analyst resistance target of $148.47 at $150.46, offering -2.2% implied upside while the 7.7% downside to the stop-loss creates an unfavorable risk/reward profile at current entry levels.

Stable
Warnings
Expectation
Analyst targets are revised upward above $165 within 12 months as the earnings beat streak continues and volume trends normalize.

CounterLarge-cap consumer staple stocks regularly trade above analyst targets due to their defensive premium; institutional demand and index weighting can sustain above-target prices for extended periods.

Per-dimension breakdown

Value

4.7/10data confidence 100%
ComponentSub-score
P/E5.8
P/S7.5
EV/EBITDA2.8
Fwd P/E6.0
PEG2.9
Analyst target4.0
  • Forward P/E: 21.5x
  • PEG: 4.27

Quality

7.5/10data confidence 100%
ComponentSub-score
ROE10.0
ROA7.3
Gross margin6.2
Op margin9.2
Net margin9.6
Current ratio2.9
FCF quality5.8
Moat7.6
Piotroski F8.9
  • Excellent ROE: 31%
  • Strong margins: 19%
  • Earnings quality warning: 77% FCF/NI
  • Wide economic moat

Growth

3.8/10data confidence 67%
ComponentSub-score
Rev growth4.3
EPS growth3.2

Momentum

6.6/10data confidence 100%
ComponentSub-score
RSI5.0
MACD10.0
OBV10.0
MA position8.0
Volume0.0
  • Volume accumulation (rising OBV)
  • Above 200-MA but MA slope flat

Sentiment

6.4/10data confidence 100%
ComponentSub-score
Analyst rating7.5
Price target6.3
erm sentiment4.8

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

5.9/10data confidence 80%
ComponentSub-score
value rank2.4
quality rank8.7
growth rank7.5
  • Superior ROE vs peers
  • Best-in-class margins

Technical

4.4/10data confidence 100%
ComponentSub-score
bollinger3.1
support resistance2.1
52w position8.1

Risk (lower is worse)

7.6/10data confidence 100%
ComponentSub-score
short interest9.4
days to cover7.5
volatility7.4
put call9.0
implied vol7.4
max pain risk3.0
beta10.0
debt equity6.9
  • Above max pain $85
  • Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

6.0/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg4.1
dividend safety6.0
  • Perfect beat streak: 4Q
  • Dividend: 280.0%

How the verdict was assembled

Engine trigger

Maintain position. Not compelling to add more.

Engine technical detail
verdict_path: L4:PATH_F_HOLD
Passed (8)
  • MOMENTUM:6.6>=5.5
  • INSIDER:OK
  • DEATH_CROSS:QUALITY_MOMENTUM_EXEMPT
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:34d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.3=NEGATIVE
Warning (1)
  • DEATH_CROSS:quality=7.5>=7.5+momentum=6.6>=5.0 exempted
Reward-to-Risk
-0.28
Upside
-2.1%
Downside
7.6%
Sizing output
AVOID

SetupMOMENTUM_CONT Trend continuation, RSI 68, MACD bullish

EdgeNO_EDGE No clear edge identified

SuitabilityCONSERVATIVE Beta 0.39<0.8, Div 280.0%, Q=7.5

Investment implication

None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:6.6>=5.5. Top dim: Risk (lower is worse) at 7.6; weakest: Growth at 3.8. No conviction either direction.

The strongest dimensions are Risk (lower is worse) at 7.6, Quality at 7.5, and Momentum at 6.6; the weakest are Growth at 3.8, Technical at 4.4, and Value at 4.7. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.28 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Procter & Gamble has beaten EPS estimates in all 4 most recent quarters with an average upside surprise of 3.1%, combined with a wide economic moat score of 7.6 and a Piotroski F-Score of 8/9, marking it as a high-quality compounder.

    Trip ifEPS falls below $1.45 per quarter for 2 consecutive quarters, declining more than 8% below the current $1.59-$1.99 recent delivery range.

  • P2Procter & Gamble generates a 31% return on equity with 19% operating margins and ranks in the top decile of consumer staple peers on both ROE and margin quality, demonstrating durable pricing power across its household brands.

    Trip ifOperating margin falls below 15% for 2 consecutive reported quarters, indicating a decline of more than 4 percentage points from current levels.

  • P3Procter & Gamble has high-priority concentration risks in non-US operations and single-source suppliers for key inputs, creating two structural vulnerabilities to geopolitical disruption and supply chain shocks.

    Trip ifA geopolitical event or supply chain disruption causes disclosed revenue impact exceeding 3% in any single reported quarter.

  • P4The stock is priced above the analyst resistance target of $148.47 at $150.46, offering -2.2% implied upside while the 7.7% downside to the stop-loss creates an unfavorable risk/reward profile at current entry levels.

    Trip ifAnalyst consensus price target falls below $138, reducing implied forward upside to less than 0% and signaling a fundamental re-rating downward.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks PG Why this verdict